Prior studies have reported that 1 in 4 patients experience recurrent chest pain (CP) after acute myocardial infarction (AMI). 1, 2 Although these patients may experience angina secondary to incomplete revascularization or recurrent ischemic events, others present with noncardiac CP syndromes that can be difficult for them to distinguish from angina or a recurrent acute coronary syndrome. 3, 4 In fact, prior studies have indicated that 90% of patients diagnosed as having noncardiac CP in the general population continue to complain of CP at 2 years. 5 This often leads to recurrent evaluations, which are associated with high resource utilization and cost. 3, [6] [7] [8] Although substantial effort has been directed toward protocols to efficiently risk stratify patients presenting to the hospital with CP, 9,10 many of these patients are still hospitalized for further evaluation. Moreover, because the Centers for Medicare and Medicaid Services now reduce payments to hospitals with high readmission rates in the 30 days after AMI, 11 understanding the frequency and impact of noncardiac CP hospitalizations post-AMI has become increasingly important.
Currently, the frequency of noncardiac CP after AMI and its association with health-related quality of life are unknown. To identify the incidence of hospitalization with noncardiac CP in the first year after AMI and to determine its association with patients' health status, we analyzed data from the 24-center Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) study. TRIUMPH collected detailed data about patient characteristics and health status, as well as physicianadjudicated hospitalization data. To contextualize these results, we also examined the health status outcomes associated with cardiac CP hospitalization, and compared the impact of noncardiac and cardiac CP hospitalization on health status outcomes. Finding a high frequency of noncardiac CP admissions and a strong association with health status would underscore the importance of further studying and developing treatment strategies and protocols for this condition.
Methods

TRIUMPH study
A total of 4,340 patients were enrolled in the TRIUMPH study between April 11, 2005 , and December 31, 2008 . Patients were at least 18 years with elevated cardiac biomarkers (troponin or creatine kinase-MB fraction assessed within 24 hours of admission) and with supporting evidence of an AMI (electrocardiographic ST-segment changes or prolonged ischemic signs/ symptoms). Each patient underwent a standardized interview by research staff to document sociodemographic and clinical data, as previously described. Patients were then contacted for follow-up interviews at 1, 6, and 12 months after AMI. All patients signed an informed consent form after institutional review board approval was obtained at each participating center.
A separate informed consent was obtained from TRIUMPH participants to collect their rehospitalization records for adjudication. During telephone interviews at 1, 6, and 12 months, patients were asked to report any admissions to any hospital. Any reported admissions led to retrieval of all hospital records over the year after AMI from the reported hospital. These documents were independently reviewed by at least 2 members of a physician adjudication panel to determine cause of hospitalization and document in-hospital processes of care. In the event that the initial 2 reviewers disagreed on the cause for hospitalization, a third reviewer independently reviewed the documents to ascertain the cause of hospitalization.
Study population
Of the 4,340 patients enrolled in TRIUMPH, 24 died before discharge from the index AMI hospitalization and 310 did not consent to release of medical records for the rehospitalization follow-up study. Among the remaining 4,006 patients, 631 did not complete any follow-up interviews and 248 did not have physicianadjudicated hospitalization data, most often due to refusal of the admitting hospital to provide the medical records. We further excluded 28 patients who had only a hospitalization for staged percutaneous coronary intervention (PCI), yielding 3,099 eligible patients participating in the follow-up rehospitalization study with complete follow-up data during the year after their AMI hospitalization.
Definitions and adjudication process
Each CP hospitalization was classified as noncardiac or cardiac by the physician adjudication panel. Patients were classified as having a noncardiac CP hospitalization if they were admitted with atypical or noncardiac description of CP 12, 13 and the following conditions were absent: elevated cardiac biomarkers, evidence of myocardial ischemia on noninvasive stress tests, flowlimiting epicardial coronary stenosis (N70%), or abnormal fractional flow reserve (b0.80). Specifically, patients with normal myocardial perfusion on stress myocardial perfusion imaging or normal wall motion on stress echocardiography who described atypical or noncardiac CP were classified as having noncardiac CP. The treating physician's diagnosis of noncardiac CP was also used to identify noncardiac CP hospitalizations. Cardiac CP was categorized according to standard definitions of stable angina, unstable angina, non-ST-elevation MI and STelevation MI (STEMI) after reviewing hospital records. The adjudicators specifically focused on in-hospital testing, including cardiac biomarkers, electrocardiogram findings, stress testing and angiographic findings of severe epicardial stenoses or fractional flow reserve b0.80, and the treating physician's diagnoses. Specific cardiac CP definitions are listed in Supplementary Table I . Any patient with no hospitalizations or cardiac hospitalizations unrelated to CP, or with hospitalization for noncardiac reasons in the first year after AMI was categorized as not having had a CP hospitalization. Any patient admitted for both cardiac and noncardiac CP during follow-up was classified in the cardiac CP group.
Outcome measures
The primary outcome was disease-specific health status, which was evaluated using the quality of life domain of the disease-specific Seattle Angina Questionnaire (SAQ QoL). The SAQ is a 19-item self-administered instrument, with a 4-week recall period, that quantifies coronary artery disease (CAD)-specific health status.
14 At each follow-up telephone interview, the SAQ and the Short Form 12 (SF-12) were administered by trained study nurses to record patients self-reported health status. The SAQ has well-established validity and reliability and is more sensitive to clinical change than generic health status measures. SAQ scores are also independently associated with costs, morbidity, and mortality among patients with CAD. [15] [16] [17] Scores range from 0 to 100, where higher scores indicate better function, fewer symptoms, and better quality of life. The SAQ asks patients to report CP, tightness, or angina, but does not specifically distinguish between pain of an anginal character and other causes of CP. Accordingly, it is likely to effectively quantify the health status impact of CP regardless of its etiology.
As a secondary outcome, we also evaluated general health status using the generic SF-12. 18 The SF-12 consists of 12 questions assessing 2 domains, the physical component (PCS) and the mental component (MCS) scores, which provide an assessment of patients' overall physical and mental function. A score of 50 is normalized to the mean health status of the US population, and each 10 points represents 1 SD from that mean. The lower the score, the worse the patient perceives his or her generic health status, and lower scores have been shown to correlate with a greater likelihood for admissions due to cardiac causes and death.
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Statistical analyses
We compared the baseline demographics, clinical characteristics, and treatments of patients with noncardiac CP hospitalization and cardiac CP hospitalization and those with no CP hospitalizations during the follow-up period. Continuous variables were reported as the mean ± SD and differences were compared using 1-way analysis of variance. Categorical variables were compared using χ 2 tests. To understand the association between CP hospitalization and patients' health status (comparing patients hospitalized with noncardiac CP vs no CP hospitalizations, and those with cardiac CP hospitalization vs no CP hospitalizations; Figure 1 ), we then fit 3 hierarchical repeated-measures linear models to assess the association between CP hospitalization and each of the 3 health status outcomes: the disease-specific SAQ QoL and the generic SF-12 PCS and MCS domains. This repeatedmeasures approach included all follow-up health status assessments (1, 6, and 12 months). To compare the relative health status impact of noncardiacvs cardiac CP, we also directly compared the difference in health status scores among patients hospitalized with cardiac vs noncardiac CP. All models adjusted for important potential confounders that were identified based on either clinical judgment or a statistically significant difference between groups (P b .05) in univariate analyses. Patients' baseline health status scores were included in each analysis examining that same health status outcome, along with age, race, sex, smoking status, prior coronary artery bypass grafting (CABG), peripheral arterial disease, diabetes mellitus, insurance status (insurance vs no insurance), Patient Health Questionnaire-9 depression scale score, 22, 23 Perceived Stress Scale-4 score, 24 working status, marital status, in-hospital revascularization during index admission (PCI vs none, CABG vs none), number of diseased vessels on coronary angiography during index hospitalization, STEMI vsnon-ST-elevation MI, and cardiac rehabilitation during follow-up. Finally, to contextualize the association of noncardiac CP with health status outcomes, we used the same multivariable modeling to compare health status outcomes again between patients hospitalized with noncardiac and cardiac CP.
In addition, we performed a time-to-rehospitalization analysis using the Kaplan-Maier method to and present these curves to show the timing of rehospitalization events among the different groups across the follow-up period. Finally, to identify additional independent predictors of health status in follow-up after AMI, we examined the relationship between covariates in the multivariable linear regression models and each health status outcome.
Sensitivity analyses
We also evaluated for potential bias related to missing follow-up data. A total of 1,189 patients with missing follow-up data over the 1-year follow-up period, who were not included in our primary analysis, were included in a sensitivity analysis along with the 3,099 patients who had complete follow-up data. We generated a propensity score for likelihood of having complete follow-up data, including all baseline demographic, clinical, and treatment variables in a nonparsimonious logistic regression model. Multivariable modeling for health status outcomes and predictors of noncardiac CP hospitalization were then repeated to determine whether missing follow-up data influenced our results after weighting using the inverse of the propensity score to participate in follow-up. Essentially, this analysis assigns greater weight to the outcomes of a patient who had complete follow-up who was statistically most similar to a patient without complete follow-up, and less weighting to the outcomes of a patient with propensity score consistent with high likelihood of follow-up.
To study the association between timing of rehospitalizations, type (cardiac, noncardiac, and none), and health status, we conducted further sensitivity analyses in which the patients were identified who were hospitalized for evaluation of CP symptoms within 1 month after the 30-day and 6-month assessments. These patients were categorized according to the type of CP and were compared with patients who were not hospitalized with CP over the follow-up period. Scores on each health status measure across these groups are presented in Supplementary Table II , but across measures, health status was significantly worse among patients who were hospitalized with noncardiac and cardiac CP within a month after assessment, in comparison to patients who had no hospitalizations for CP.
The authors are solely responsible for the design and conduct of this study, all study analyses, and the drafting and editing of the manuscript and its final contents.
Results
Patient characteristics
The baseline characteristics of patients with noncardiac CP, cardiac CP, and no CP hospitalizations are presented in Table I . Briefly, compared with patients with no CP hospitalization and with noncardiac CP hospitalization, patients with cardiac CP hospitalization were more likely to be nonwhite, to have cardiac comorbidities (including diabetes, hypertension, prior MI, prior PCI, and prior CABG), and to be depressed and were less likely to work full or part time. Moreover, no differences were found in access to care metrics at baseline or at 6 or 12 months post-AMI. We report that cardiac catheterization was performed on 43% vs 5% vs 5% of patients with cardiac CP hospitalization, noncardiac CP hospitalization, and no CP hospitalizations, respectively. Percutaneous coronary intervention during 1-year follow-up was performed on 31% of patients with cardiac CP hospitalization vs 7% in patients with no CP hospitalizations. None of the patients with noncardiac CP hospitalization received PCI.
Frequency of noncardiac CP hospitalization
In the year after an AMI admission, 318 (10.3%) of 3,099 patients were hospitalized for evaluation and management of CP. Of these, 92 (28.9%) were admitted for noncardiac CP and the remaining 226 patients were hospitalized with cardiac CP: 70 (31%) with recurrent AMI, 131 (58.0%) with unstable angina, and 25 (11.0%) with stable angina. The timing of cardiac and noncardiac CP hospitalizations over the follow-up period is presented in Figure 2 and Supplementary Figure 4 .
CP hospitalization and health status outcomes
Both noncardiac CP and cardiac CP hospitalizations were associated with significantly worse disease-specific health status over the follow-up period as compared with patients without a CP hospitalization. After adjusting for patient characteristics, those hospitalized with noncardiac CP had significantly lower SAQ QoL scores than did those without a CP hospitalization (adjusted difference of −8.1 points, 95% CI −11.4 to −4.8) (Figures 3 and 4 ) similar to patients admitted with cardiac CP (adjusted difference of −9.5 points, 95% CI −11.7 to −.73) as compared with those without a CP hospitalization. The SAQ QoL scores over the year after AMI were similar between those with noncardiac and cardiac CP admissions (difference in adjusted scores of 0.6 points, 95% CI −3.2 to 4.5).
Similarly, general health status was worse among patients hospitalized with noncardiac CP than those who were not hospitalized with CP (Figures 3 and 4) . Patients presenting with noncardiac CP (adjusted difference in SF-12 PCS scores of −2.5 points, 95% CI −4.2 to −0.8) or cardiac CP (adjusted difference in SF-12 PCS scores of −3.4 points, 95% CI −4.5 to −2.2) reported poorer physical functioning than did those without hospitalization for with CP. There were no significant differences in the adjusted SF-12 PCS scores when comparing patients with noncardiac CP hospitalizations and those who had cardiac CP hospitalizations (difference of 0.9 points, 95% CI −1.1 to 2.9).
Mental health scores, as assessed by the adjusted SF-12 MCS, were lower in patients hospitalized with noncardiac CP as compared with those who were not hospitalized with CP (difference −3.5 points, 95% CI −5.1 to −1.9). Patients hospitalized with cardiac CP also had lower SF-12 MCS scores compared with patients who had no CP hospitalizations (−1.4 points, 95% CI −2.5 to −0.4). In contrast to the other health status measures, patients with noncardiac CP hospitalization had worse mental health status over the follow-up period than did patients hospitalized with cardiac CP (SF-12 MCS adjusted difference −2.0 points, 95% CI −3.9 to −0.2). We repeated the multivariable modeling process, using the same model structure and covariates, for each SAQ subscale and the SAQ Overall Summary Score (Supplementary Figure 1) . These results were consistent with findings on the SAQ QoL scale indicating worse health status among patients with either cardiac or noncardiac CP.
Other clinical characteristics independently associated with health status in recovery after AMI are presented in Supplementary Figure 2A -C. Older age, current work employment, being married, and in-hospital revascularization during the index hospitalization were associated with better quality of life. However, smoking, presenting with STEMI, female gender, depression and stress, having no insurance, and history of CABG before the index AMI were all associated with worse quality of life.
Sensitivity analyses
After adjusting our analyses for the inverse of the propensity to have complete follow-up data, we found no significant differences in our results, suggesting that there was little bias due to missing follow-up data.
Adjudication process
Initially, 2 physicians adjudicated each medical record, and in case of disagreement, the medical record was sent to a third physician for review (blinded to initial 2 reviews). In case of continued disagreement among the 3 reviewers, more reviewers (blinded to initial reviews) were invited to help with the adjudication. We report that the agreement between the initial 2 reviewers was high for all the 3 groups studied (75% vs 71% vs 85% for cardiac CP vs noncardiac CP vs no CP hospitalizations, respectively). In the cardiac CP hospitalization group, 21% needed a third reviewer and only 4% needed a fourth reviewer. In the noncardiac CP hospitalization group, 23%, 3%, and 2% needed a third, fourth, and fifth reviewer, respectively.
Mortality
Mortality in the first 2 years after AMI was numerically lower in those with noncardiac CP hospitalization (although with low event rates) but not significantly different compared with those with cardiac CP hospitalization and those without CP hospitalizations (2 [2.2%] vs 18 [8.0%] vs 188 [6.8%], respectively; P = .17). Moreover, the 2-year mortality rates were also not significantly different between noncardiac CP and cardiac CP groups (P = .07).
Predictors of noncardiac CP hospitalization
We identified several independent predictors of both noncardiac CP and cardiac CP hospitalization. Compared with patients without a hospitalization for CP, patients with a greater burden of angina at the time of their index AMI, women, and diabetic patients were more likely to be admitted with cardiac CP, but these patient factors were not associated with admission for noncardiac CP (Supplementary Figure 3) . Current smokers were less likely to present with noncardiac CP, whereas there was no difference in the likelihood of hospitalization with cardiac CP in follow-up between smokers and nonsmokers. Married patients were less frequently admitted to the hospital for evaluation of CP regardless of etiology, whereas those with prior CABG (before their index AMI) were more likely to be hospitalized with both cardiac CP and noncardiac CP. Individuals treated with PCI during the index hospitalization were more likely to be hospitalized with cardiac CP than those who did not undergo revascularization.
Discussion
In an era of increasing attention on post-AMI rehospitalization, 25 understanding the frequency and types of CP hospitalization after AMI and the clinical significance of these CP hospitalizations is increasingly important. To our knowledge, there are no prior studies of the Health status scores from baseline through 1 year of follow-up. A, SAQ QoL scores at baseline and at 1, 6, and 12 months for patients with noncardiac CP, cardiac CP, and no CP. B, Baseline and at 1-, 6-, and 12-month scores on the SF-12 PCS scale. C, Baseline and at 1-, 6-, and 12-month scores on the SF-12 MCS scale.
incidence and clinical implications of noncardiac CP hospitalizations after AMI. We leveraged a multicenter AMI registry with carefully adjudicated data on all rehospitalizations in the first year after AMI to address this gap in knowledge. We found that hospitalization for CP within the first year after AMI occurred in 10% of patients, and that 1 in 3 patients hospitalized with CP presented with a noncardiac etiology for their symptoms. Noncardiac CP hospitalization was associated with poorer disease-specific and general health status throughout the first year of recovery as compared with those not admitted with recurrent CP and was associated with similar decrements in health status as compared with patients admitted for cardiac CP. In fact, although noncardiac CP hospitalization was associated with slightly worse impairment of mental functioning than cardiac CP hospitalization, the difference was clinically modest and unlikely to be clinically significant.
Our study extends prior reports regarding the association of noncardiac CP with patients' perceived quality of life. Prior studies have examined patients without known CAD, often identified in the emergency department or in outpatient clinics. These reports have suggested that patients with noncardiac CP may have poor health status, 26 and have similar or even greater levels of anxiety compared with those who have cardiac CP. [27] [28] [29] Importantly, it has been shown that many patients with noncardiac CP are not reassured after being informed that their CP is not of cardiac origin, often remaining anxious and seeking further medical evaluation. 8 Our report examines the relationship between noncardiac CP and health status in a much higher-risk population with recent AMI. Our data suggest a strong association between noncardiac CP admissions and poorer health status in these patients with established CAD, indicating a clear need to better identify and treat the underlying causes of noncardiac CP.
Noncardiac CP has been shown to commonly occur with several conditions such as gastrointestinal, musculoskeletal, and psychiatric disorders. 30 Gastrointestinal diagnoses such as reflux disease, esophageal spasm, and cholelithiasis have been found to be important causes of symptoms in patients presenting with noncardiac CP. 3, 4, 31 In a small study of patients with CAD who had continued atypical CP despite medical therapy or revascularization, it was found that nearly two-thirds had gastroesophageal reflux disease, and most of these patients experienced significant symptom relief with treatment. 4 Similarly, musculoskeletal CP is also a common, treatable cause of symptoms in a many patients with noncardiac CP. [31] [32] [33] [34] Moreover, psychiatric conditions are prevalent among patients with noncardiac CP Figure 4 Association between cardiac or noncardiac CP hospitalization and health status after AMI.
and include panic, anxiety, and depressive disorders. 35 Prior studies have shown that cognitive behavioral therapy is an effective treatment option for patients presenting with noncardiac CP. 36, 37 To date, however, no systematic strategies to proactively evaluate these potential etiologies of noncardiac CP have been developed or tested. Given that as many as a third of CP admissions are not cardiac in etiology, systematically seeking to identify and intervene in high-risk patients might be a cost-effective intervention that may also improve patients' health status recovery after an AMI. The use of prediction models on discharge to identify patients with high likelihood of rehospitalizations should be encouraged. Future studies should focus on developing protocols that aim to identify patients with noncardiac CP that can be managed effectively in the outpatient setting to prevent extensive emergency room evaluations and admission to the hospital.
Several limitations of the present study should be considered in the interpretation of these data. First, we were not able to adjudicate the causes of patients' noncardiac CP and angina secondary to small-vessel disease or microvascular disease cannot be excluded in the noncardiac CP group. However, our definition of noncardiac CP was consistent with prior studies and represents some of the first insights into the frequency and clinical importance of these symptoms in patients with established CAD. Future studies are needed to determine the frequency of various noncardiac CP syndromes, such as panic disorder, musculoskeletal pain, and gastroesophageal reflux disease, among others. Second, not all TRIUMPH patients participated in the follow-up rehospitalization study, and patients were also excluded who were not able to complete the follow-up process. Because these patients may differ from those who participated throughout the entire follow-up period, selection bias cannot be excluded. However, our results weighted for the inverse of the propensity to have complete follow-up suggested that no significant bias was introduced into our analyses by missing data. The TRIUMPH rehospitalization substudy did not collect detailed information for emergency department encounters that did not lead to inpatient admission. Accordingly, we were unable to examine variability in hospitalization rates among all-comers with CP symptoms, and we were unable to examine either the association between outpatient emergency department evaluations and health status or the predictors of inpatient vs outpatient evaluation. Moreover, follow-up health status assessments in TRIUMPH were conducted at 1, 6, and 12 months after enrollment. Accordingly, for many hospitalizations, there was no health status assessment in the month preceding hospital admission. Although our sensitivity analyses suggest an even stronger relationship between noncardiac CP hospitalization and health status in the month before hospitalization, greater granularity as to the exact temporal relationships between CP syndromes and health status cannot be obtained from this study, and future efforts to collect patients' health status at more frequent interviews will be needed. TRIUMPH enrolled patients between 2005 and 2008, and thus, the use of high-sensitivity troponins and other advanced imaging modalities to risk stratify patients with CP might not reflect current practice. Finally, although we adjusted for potential confounders in the relationship between CP and health status outcomes, unmeasured and residual confounding cannot be excluded in this observational study.
Conclusions
We found that noncardiac CP accounts for 1 in 3 CP hospitalizations in follow-up after AMI and is associated with impaired quality of life over the year after an AMI. Although the magnitude of the association of noncardiac CP and cardiac CP with disease-specific quality of life and general physical functioning is similar, noncardiac CP was associated with a slightly greater impairment in patients' mental health which was clinically modest and unlikely to be clinically significant. In light of the significant health status impairment associated with noncardiac CP, better describing the causes, prevention, and treatment of noncardiac CP is an important area for future research.
Author contributions
Mohammed Qintar, MD: analysis of data, interpretation of data, drafting and revisions of manuscript.
Yuanyuan Tang, PhD: statistical analyses, revisions of manuscript. Donna M. Buchanan, PhD: interpretation of data, drafting and revisions of manuscript.
Paul S. Chan, MD, MSc: interpretation of data, drafting and revisions of manuscript.
Amit P. Amin, MD, MSc: interpretation of data, review and revisions of manuscript.
John A. Spertus, MD MPH: conception and design of study, funding of study, coordination of study, interpretation of data, drafting and revisions of manuscript.
Adam C. Salisbury, MD, MSc: conception and design of study, analysis of data, interpretation of data, drafting and revisions of manuscript.
Disclosures
Dr Spertus owns the copyright for the Seattle Angina Questionnaire. All other authors have no disclosures.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.ahj.2017.01.001.
